#	Pagina
attuale pagina	/open-h2020/projects/217898/index.html

Opendata, web and dolomites

Primavera SIGNED

Primavera: immunobiotics for treating early stage Age-related Macular Degeneration (AMD)

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

Primavera project word cloud

Explore the words cloud of the Primavera project. It provides you a very rough idea of what is the project "Primavera" about.

efficiency burden age found caused retina multivitamin expensive details formula primavera prepared colours innovative macula area small disease 10 later economic macular causes social hidden nor provenly commercialisation food compounds booster people effectiveness damage usa alterations supress sight benefits degeneration medical visual prevalence retinal immunobiotic chronic countries amd functions expectedly seeing read market central company stage approved screening detection treatment industrialized progressive threatening drive difficulty metabolic

Project "Primavera" data sheet

The following table provides information about the project.

Coordinator	NUTRIPHARMA HUNGARIA TAP ES GYOGYSZER ELOALLITO KFT Organization address address: TAROGATO LEJTO 8 II EM 5 city: BUDAPEST postcode: 1021 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Hungary [HU]
Project website	http://www.nutripharma.hu/nutripharma/primavera-project/
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2018
Duration (year-month-day)	from 2018-08-01 to 2019-01-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	NUTRIPHARMA HUNGARIA TAP ES GYOGYSZER ELOALLITO KFT NUTRIPHARMA HUNGARIA TAP ES GYOGYSZER ELOALLITO KFT Organization address address: TAROGATO LEJTO 8 II EM 5 city: BUDAPEST postcode: 1021 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HU (BUDAPEST)	coordinator	50˙000.00

Map

Project objective

Age-related Macular Degeneration (AMD) is a chronic, progressive, sight-threatening disease, caused by the damage of the macula, the small, central area of the retina. People with AMD have difficulty seeing colours, details and later, to read, to drive and to work. The disease causes significant social, medical, and economic burden. Its prevalence (hidden in early stage) is estimated more 8-10% in industrialized countries (EU, USA) for people over 40 years. However, neither screening method is proposed for the early detection of AMD nor its effective treatment has been approved yet. The multivitamin products, found on the market today, have provenly low efficiency to supress early stage AMD, and rather expensive compared to their low-effectiveness. The objective of primavera project is the commercialisation of a new medical food for treatment of AMD. Our new and unique formula, Primavera, is based on immunobiotic compounds, prepared by our innovative technology, and metabolic booster compounds. The new and unique formula will expectedly have benefits on both visual functions and retinal alterations in early AMD. The success of the project will promote the growth of our company.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PRIMAVERA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PRIMAVERA" are provided by the European Opendata Portal: CORDIS opendata.